Qube Research & Technologies (QRT)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-145,111
| Closed | -$19.8M | – | 3005 |
|
|
2024
Q4 | $19.8M | Sell |
145,111
-618,244
| -81% | -$84.4M | 0.03% | 539 |
|
|
2024
Q3 | $88M | Buy |
763,355
+161,635
| +27% | +$18.6M | 0.13% | 138 |
|
|
2024
Q2 | $82.8M | Buy |
601,720
+349,889
| +139% | +$48.2M | 0.13% | 154 |
|
|
2024
Q1 | $34.7M | Buy |
251,831
+82,221
| +48% | +$11.3M | 0.06% | 350 |
|
|
2023
Q4 | $22.3M | Buy |
169,610
+33,840
| +25% | +$4.46M | 0.04% | 400 |
|
|
2023
Q3 | $15.3M | Sell |
135,770
-92,695
| -41% | -$10.4M | 0.04% | 414 |
|
|
2023
Q2 | $21.5M | Sell |
228,465
-73,798
| -24% | -$6.96M | 0.08% | 299 |
|
|
2023
Q1 | $30.6M | Buy |
302,263
+79,446
| +36% | +$8.04M | 0.13% | 162 |
|
|
2022
Q4 | $26.6M | Buy |
222,817
+214,655
| +2,630% | +$25.6M | 0.14% | 181 |
|
|
2022
Q3 | $867K | Buy |
+8,162
| New | +$867K | 0.01% | 1207 |
|
|
2022
Q1 | – | Sell |
-70,739
| Closed | -$6.03M | – | 2793 |
|
|
2021
Q4 | $6.03M | Buy |
+70,739
| New | +$6.03M | 0.05% | 498 |
|
|
2021
Q3 | – | Sell |
-45,085
| Closed | -$4.39M | – | 2577 |
|
|
2021
Q2 | $4.39M | Buy |
+45,085
| New | +$4.39M | 0.05% | 441 |
|
|
2021
Q1 | – | Sell |
-48,046
| Closed | -$4.61M | – | 2239 |
|
|
2020
Q4 | $4.61M | Sell |
48,046
-108,902
| -69% | -$10.4M | 0.07% | 335 |
|
|
2020
Q3 | $15.1M | Buy |
156,948
+121,096
| +338% | +$11.6M | 0.22% | 102 |
|
|
2020
Q2 | $4.37M | Buy |
35,852
+29,224
| +441% | +$3.57M | 0.06% | 395 |
|
|
2020
Q1 | $574K | Sell |
6,628
-3,332
| -33% | -$289K | 0.02% | 523 |
|
|
2019
Q4 | $1.07M | Buy |
+9,960
| New | +$1.07M | 0.03% | 581 |
|